BioCentury
ARTICLE | Company News

Janssen, Immune Biosolutions partner to discover, develop antibodies for cancer

August 10, 2018 6:50 PM UTC

Immune Biosolutions Inc. (Sherbrooke, Quebec) and the Janssen Biotech Inc. unit of Johnson & Johnson (NYSE:JNJ) partnered to discover and develop antibodies against multiple undisclosed cancer targets. The partners will utilize Immune Biosolutions' Nebula antibody discovery platform...